UTERINE LEIOMYOMA PROLAPSE

This adverse event was reported 5 times

UTERINE LEIOMYOMA PROLAPSE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE 1 0.0007
1 TIZANIDINE HYDROCHLORIDE 1 0.0001
2 BENRALIZUMAB 1 0.0000
3 LEVOCETIRIZINE DIHYDROCHLORIDE 1 0.0000
4 ERGOCALCIFEROL 1 0.0000
5 FLUTICASONE PROPIONATE NASAL 1 0.0000
6 BELIMUMAB 1 0.0000
7 RIOCIGUAT 1 0.0000
8 TAPENTADOL HYDROCHLORIDE 1 0.0000
9 DOCUSATE SODIUM 1 0.0000
See all drugs enriched for association with UTERINE LEIOMYOMA PROLAPSE